Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 2
2011 2
2012 1
2014 2
2015 4
2016 6
2017 3
2018 3
2019 4
2020 8
2021 9
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a physiologic vasculogenic fibroblast state to achieve tissue repair.
Pal D, Ghatak S, Singh K, Abouhashem AS, Kumar M, El Masry MS, Mohanty SK, Palakurti R, Rustagi Y, Tabasum S, Khona DK, Khanna S, Kacar S, Srivastava R, Bhasme P, Verma SS, Hernandez E, Sharma A, Reese D, Verma P, Ghosh N, Gorain M, Wan J, Liu S, Liu Y, Castro NH, Gnyawali SC, Lawrence W, Moore J, Perez DG, Roy S, Yoder MC, Sen CK. Pal D, et al. Among authors: castro nh. Nat Commun. 2023 Feb 28;14(1):1129. doi: 10.1038/s41467-023-36665-z. Nat Commun. 2023. PMID: 36854749 Free PMC article.
Hyperprogressive Disease: Main Features and Key Controversies.
Arasanz H, Zuazo M, Bocanegra A, Chocarro L, Blanco E, Martínez M, Morilla I, Fernández G, Teijeira L, Morente P, Echaide M, Castro N, Fernández L, Garnica M, Ramos P, Escors D, Kochan G, Vera R. Arasanz H, et al. Among authors: castro n. Int J Mol Sci. 2021 Apr 3;22(7):3736. doi: 10.3390/ijms22073736. Int J Mol Sci. 2021. PMID: 33916696 Free PMC article. Review.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Auclin E, Benitez-Montanez J, Tagliamento M, Parisi F, Gorria T, Garcia-Campelo R, Dempsey N, Pinato DJ, Reyes R, Albarrán-Artahona V, Dall'Olio F, Soldato D, Hendriks L, Nana FA, Tonneau M, Lopez-Castro R, Nadal E, Kazandjian S, Muanza T, Blanc-Durand F, Fabre E, Castro N, Arasanz H, Rochand A, Besse B, Routy B, Mezquita L. Auclin E, et al. Among authors: castro n. Lung Cancer. 2023 Apr;178:116-122. doi: 10.1016/j.lungcan.2023.02.002. Epub 2023 Feb 4. Lung Cancer. 2023. PMID: 36812760
An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes.
Martorell M, Castro N, Victoriano M, Capó X, Tejada S, Vitalini S, Pezzani R, Sureda A. Martorell M, et al. Among authors: castro n. Evid Based Complement Alternat Med. 2021 Sep 20;2021:3313419. doi: 10.1155/2021/3313419. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34589130 Free PMC article. Review.
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Jarava Mantecón CJ, Gomes Pérez VO, Bordils A, Lacueva J, Marin Franco AJ, Delgado Conde P, Muñoz Ramos P, Calderón González C, Cazorla López JM, Sanchez-Rodriguez J, Sánchez Horrillo A, Monzón Vázquez TR, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Nephrol Dial Transplant. 2023 Mar 31;38(4):969-981. doi: 10.1093/ndt/gfac307. Nephrol Dial Transplant. 2023. PMID: 36423334
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.
Dias Assis BR, Gomes IP, de Castro JT, Rivelli GG, de Castro NS, Gomez-Mendoza DP, Bagno FF, Hojo-Souza NS, Chaves Maia AL, Lages EB, da Fonseca FG, Ribeiro Teixeira SM, Fernandes AP, Gazzinelli RT, Castro Goulart GA. Dias Assis BR, et al. Among authors: de castro ns. Nanomedicine (Lond). 2023 Aug;18(18):1175-1194. doi: 10.2217/nnm-2023-0122. Epub 2023 Sep 15. Nanomedicine (Lond). 2023. PMID: 37712604 Clinical Trial.
54 results